Hepatitis Monthly

Metrics & Ranking

Impact Factor

Year	Value
2025	0.6
2024	0.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.196

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	48

Journal Rank

Year	Value
2024	21444

Journal Citation Indicator

Year	Value
2024	62

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease

  Citation: 89

  Authors: Alireza, Vahid, Mohammad Ebrahim, Seyed Moayed, Ali

• The Therapeutic Use of Analgesics in Patients with Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations

  Citation: 89

  Authors: Farnad, Mahsa, Saeid, Seyed Moayed

• Opioid Drugs in Patients With Liver Disease: A Systematic Review

  Citation: 82

  Authors: Hassan, Saeid, Kavous, Sarvin, Seyed Moayed

• The Role of Aflatoxins in Hepatocellular Carcinoma

  Citation: 80

  Authors: Hui-Chen, Regina

• Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study

  Citation: 76

  Authors: Ali Akbar, Amir, Sonia, Homa

• Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

  Citation: 72

  Authors: Mehran, Zahra, Azita, Seyed Moayed, Seyed Ali

• Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

  Citation: 72

  Authors: Mostafa, Farzin, Amir, Mohammad, Seyed Moayed

• How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

  Citation: 64

  Authors: Alireza, Fourugh Azam, Azita, Alireza, Vahid, Zohreh, Reza, Hafez

• Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease? A Meta-Analysis

  Citation: 64

  Authors: Mahdi, Mohsen, Hamid, Mohammad Saeid, Seyed Moayed

• Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

  Citation: 58

  Authors: Jennifer, Jennifer

---